Anthony L Byrne
Overview
Explore the profile of Anthony L Byrne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashuro Z, Debela B, Daba C, Hareru H, Abaya S, Byrne A
Front Public Health
. 2024 Nov;
12:1424315.
PMID: 39555040
Introduction: Inadequate ventilation and improper use of personal protective equipment are often observed in many occupational settings with a high risk of dust and other fine particle exposure. Workers who...
2.
Dupnik K, Rivera V, Dorvil N, Duffus Y, Akbarnejad H, Gao Y, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae356.
PMID: 39022393
Background: The World Health Organization recommends initiating same-day antiretroviral therapy (ART) while tuberculosis (TB) testing is under way for patients with non-meningitic symptoms at HIV diagnosis, though safety data are...
3.
Dupnik K, Rivera V, Dorvil N, Akbarnejad H, Gao Y, Liu J, et al.
medRxiv
. 2024 Jan;
PMID: 38196598
Article Summary: We assessed the association between C-reactive protein (CRP) and (TB) diagnosis in symptomatic patients at HIV diagnosis. We found that CRP concentrations can improve tuberculosis risk stratification, facilitating...
4.
Dorvil N, Rivera V, Riviere C, Berman R, Severe P, Bang H, et al.
PLoS Med
. 2023 Jun;
20(6):e1004246.
PMID: 37294843
Background: Same-day HIV testing and antiretroviral therapy (ART) initiation is being widely implemented. However, the optimal timing of ART among patients with tuberculosis (TB) symptoms is unknown. We hypothesized that...
5.
Menzies N, Quaife M, Allwood B, Byrne A, Coussens A, Harries A, et al.
Lancet Glob Health
. 2021 Nov;
9(12):e1679-e1687.
PMID: 34798027
Background: Many individuals who survive tuberculosis disease face ongoing disability and elevated mortality risks. However, the impact of post-tuberculosis sequelae is generally omitted from policy analyses and disease burden estimates....
6.
Coates M, Kintu A, Gupta N, Wroe E, Adler A, Kwan G, et al.
Lancet Glob Health
. 2020 Oct;
8(12):e1489-e1498.
PMID: 33098769
Background: Non-communicable diseases (NCDs) cause a large burden of disease globally. Some infectious diseases cause an increased risk of developing specific NCDs. Although the NCD burden from some infectious causes...
7.
Byrne A, Bennett M, Chatterji R, Symons R, Thomas P
Intern Med J
. 2020 Jan;
50(1):133-134.
PMID: 31943620
No abstract available.
8.
Yeong C, Byrne A, Cho J, Sintchenko V, Crighton T, Marais B
Int J Infect Dis
. 2019 Dec;
92:175-180.
PMID: 31881274
Background: Patients with suspected pulmonary tuberculosis (PTB) are usually placed in respiratory isolation awaiting three sputum smear microscopy results for acid-fast bacilli (3AFB). GeneXpert MTB/RIF (Xpert) on a pooled sample...
9.
Byrne A, Marais B, Mitnick C, Garden F, Lecca L, Contreras C, et al.
BMC Pulm Med
. 2019 Feb;
19(1):40.
PMID: 30760258
Background: Although there are theoretical reasons for believing that asthma and atopy may be negatively correlated with tuberculosis, epidemiological studies have had conflicting findings. Objective: To determine if people with...
10.
Byrne A, Fox G, Marais B
Future Microbiol
. 2018 Mar;
13:577-588.
PMID: 29521120
Diagnostic and treatment delays contribute to increased death and disability among the 490,000 adults and children who develop multidrug-resistant (MDR) tuberculosis every year. Since the treatment of MDR tuberculosis is...